Norvista Capital (NVV) Stock Price, News & Analysis

Company Overview

Norvista Capital Corporation operates as a resource investment company and merchant bank in the United States and Canada. It invests in a portfolio of companies that are involved in the exploration of base and precious metals, such as copper, zinc, silver, gold, and lead, as well as oil and gas located in Chile, Manitoba, Yukon, Mexico, and Nevada; and oil and gas in Israel, the United States, Brazil, and Canada. The company was founded in 2014 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$0.08 to C$0.08
• 50-Day Range: C$0.08 to C$0.08
• 52-Week Range: C$0.07 to C$0.23
• Volume: 112,500 shs
• Average Volume: 116,000 shs
• Market Capitalization: C$5.26 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NVV Stock Analysis - Frequently Asked Questions

How have NVV shares performed this year?

Norvista Capital's stock was trading at C$0.08 on January 1st, 2025. Since then, NVV stock has increased by 0.0% and is now trading at C$0.08.

How do I buy shares of Norvista Capital?

Shares of NVV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Norvista Capital own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Norvista Capital investors own include Advanced Micro Devices (AMD), Altimmune (ALT), Albireo Pharma (ALBO), Alliance Data Systems (ADS), AcelRx Pharmaceuticals (ACRX) and Albertsons Companies (ACI).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Basic Materials
• Industry: Industrial Metals & Minerals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: CVE:NVV
• CIK: N/A
• Web: www.norvistacapital.com
• Phone: +1-416-5044171
• Fax: N/A
• Employees: 1,990
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.07
• Current Ratio: 11.62
• Quick Ratio: 11.58

Sales & Book Value

• Annual Sales: -C$1.27 million
• Price / Sales: -4.13
• Cash Flow: C$0.12 per share
• Price / Cash Flow: 0.63
• Book Value: C$0.11 per share
• Price / Book: 0.67

Miscellaneous

• Outstanding Shares: 70,141,000
• Free Float: N/A
• Market Cap: C$5.26 million
• Optionable: Not Optionable
• Beta: N/A